{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Influenza+and+COVID-19+Combination+A", "query": { "intervention": "Influenza and COVID-19 Combination A" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 13, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Influenza+and+COVID-19+Combination+A&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-02T05:56:29.757Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06821061", "title": "A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Influenza", "COVID-19 (Coronavirus Disease 2019)" ], "interventions": [ { "name": "Investigational Influenza Vaccine", "type": "BIOLOGICAL" }, { "name": "Investigational COVID-19 Vaccine", "type": "BIOLOGICAL" }, { "name": "Investigational Influenza and COVID-19 Combination Vaccine", "type": "COMBINATION_PRODUCT" }, { "name": "Licensed Influenza Vaccine 1", "type": "BIOLOGICAL" }, { "name": "Licensed Influenza Vaccine 2", "type": "BIOLOGICAL" }, { "name": "Licensed Influenza Vaccine 3", "type": "BIOLOGICAL" }, { "name": "Licensed COVID-19 Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "COMBINATION_PRODUCT" ], "sponsor": "BioNTech SE", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2650, "start_date": "2025-02-10", "completion_date": "2025-12-17", "has_results": false, "last_update_posted_date": "2026-01-26", "last_synced_at": "2026-10-02T05:56:29.757Z", "location_count": 31, "location_summary": "Anaheim, California • Lake Forest, California • Riverside, California + 26 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Lake Forest", "state": "California" }, { "city": "Riverside", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Walnut Creek", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06821061" }, { "nct_id": "NCT04374071", "title": "Early Short Course Corticosteroids in COVID-19", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "COVID", "Pneumonia, Viral" ], "interventions": [ { "name": "Methylprednisolone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Henry Ford Health System", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 250, "start_date": "2020-03-12", "completion_date": "2020-04-30", "has_results": false, "last_update_posted_date": "2020-05-05", "last_synced_at": "2026-10-02T05:56:29.757Z", "location_count": 1, "location_summary": "Detroit, Michigan", "locations": [ { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT04374071" }, { "nct_id": "NCT06695130", "title": "Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and Recombinant Influenza Vaccine in Adult Participants 50 Years of Age and Older", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "COVID-19 Immunization", "Influenza Immunization" ], "interventions": [ { "name": "RIV (recombinant influenza vaccine)", "type": "BIOLOGICAL" }, { "name": "rC19 (dose 1)", "type": "BIOLOGICAL" }, { "name": "RIV + rC19 (dose 1)", "type": "BIOLOGICAL" }, { "name": "RIV + rC19 (dose 2)", "type": "BIOLOGICAL" }, { "name": "RIV + rC19 (dose 3)", "type": "BIOLOGICAL" }, { "name": "RIV + rC19 (dose 4)", "type": "BIOLOGICAL" }, { "name": "Placebo (0.9% NaCl)", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 980, "start_date": "2024-11-18", "completion_date": "2026-04-03", "has_results": false, "last_update_posted_date": "2026-05-05", "last_synced_at": "2026-10-02T05:56:29.757Z", "location_count": 12, "location_summary": "Phoenix, Arizona • Cerritos, California • Vista, California + 9 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Cerritos", "state": "California" }, { "city": "Vista", "state": "California" }, { "city": "Melbourne", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06695130" }, { "nct_id": "NCT06680375", "title": "A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "COVID-19" ], "interventions": [ { "name": "Flu Seasonal /SARS-CoV-2 mRNA Dose 1", "type": "COMBINATION_PRODUCT" }, { "name": "Flu Seasonal /SARS-CoV-2 mRNA Dose 2", "type": "COMBINATION_PRODUCT" }, { "name": "Flu Seasonal mRNA", "type": "COMBINATION_PRODUCT" }, { "name": "SARS-CoV-2 mRNA Dose 1", "type": "COMBINATION_PRODUCT" }, { "name": "SARS-CoV-2 mRNA Dose 2", "type": "COMBINATION_PRODUCT" }, { "name": "Licensed Flu Seasonal", "type": "COMBINATION_PRODUCT" }, { "name": "Licensed COVID-19 mRNA", "type": "COMBINATION_PRODUCT" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "COMBINATION_PRODUCT", "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 106, "start_date": "2024-11-11", "completion_date": "2025-06-09", "has_results": false, "last_update_posted_date": "2025-09-11", "last_synced_at": "2026-10-02T05:56:29.757Z", "location_count": 9, "location_summary": "Anniston, Alabama • Rolling Hills Estates, California • Hialeah, Florida + 5 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Rolling Hills Estates", "state": "California" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06680375" }, { "nct_id": "NCT05375838", "title": "A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "SARS-CoV-2", "Influenza" ], "interventions": [ { "name": "mRNA-1073", "type": "BIOLOGICAL" }, { "name": "mRNA-1010", "type": "BIOLOGICAL" }, { "name": "mRNA-1273", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "ModernaTX, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 550, "start_date": "2022-05-13", "completion_date": "2022-12-29", "has_results": true, "last_update_posted_date": "2024-02-28", "last_synced_at": "2026-10-02T05:56:29.757Z", "location_count": 14, "location_summary": "Hollywood, Florida • Peoria, Illinois • Sioux City, Iowa + 9 more", "locations": [ { "city": "Hollywood", "state": "Florida" }, { "city": "Peoria", "state": "Illinois" }, { "city": "Sioux City", "state": "Iowa" }, { "city": "Metairie", "state": "Louisiana" }, { "city": "Norfolk", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT05375838" }, { "nct_id": "NCT06683352", "title": "A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Influenza,Human", "COVID-19" ], "interventions": [ { "name": "Investigational Influenza Vaccine", "type": "BIOLOGICAL" }, { "name": "COVID-19 Vaccine", "type": "BIOLOGICAL" }, { "name": "Investigational Influenza/COVID-19 Vaccine", "type": "COMBINATION_PRODUCT" }, { "name": "Licensed Influenza Vaccine 1", "type": "BIOLOGICAL" }, { "name": "Licensed Influenza Vaccine 2", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "COMBINATION_PRODUCT", "OTHER" ], "sponsor": "BioNTech SE", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1353, "start_date": "2024-11-11", "completion_date": "2025-07-15", "has_results": true, "last_update_posted_date": "2026-08-19", "last_synced_at": "2026-10-02T05:56:29.757Z", "location_count": 22, "location_summary": "Lake Forest, California • San Diego, California • Walnut Creek, California + 17 more", "locations": [ { "city": "Lake Forest", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Milford", "state": "Connecticut" }, { "city": "Hialeah", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06683352" }, { "nct_id": "NCT07464314", "title": "A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Influenza, Human+COVID-19" ], "interventions": [ { "name": "Investigational mRNA Seasonal Flu/COVID-19 Combination (Flu/COVm) Vaccine", "type": "BIOLOGICAL" }, { "name": "Licensed Seasonal Influenza Vaccine", "type": "BIOLOGICAL" }, { "name": "Licensed COVID-19 Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "65 Years to 85 Years" }, "enrollment_count": 225, "start_date": "2026-03-09", "completion_date": "2027-06-03", "has_results": false, "last_update_posted_date": "2026-06-30", "last_synced_at": "2026-10-02T05:56:29.757Z", "location_count": 12, "location_summary": "Anniston, Alabama • Little Rock, Arkansas • Fair Oaks, California + 9 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fair Oaks", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07464314" }, { "nct_id": "NCT05886777", "title": "A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV).", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Healthy Participants" ], "interventions": [ { "name": "Combination [RSVpreF+BNTb162b2]", "type": "BIOLOGICAL" }, { "name": "Bivalent BNT162b2 (original/Omi BA.4/BA.5)", "type": "BIOLOGICAL" }, { "name": "RSVpreF", "type": "BIOLOGICAL" }, { "name": "QIV", "type": "BIOLOGICAL" }, { "name": "Normal Saline Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 1142, "start_date": "2023-06-05", "completion_date": "2024-01-01", "has_results": true, "last_update_posted_date": "2024-12-18", "last_synced_at": "2026-10-02T05:56:29.757Z", "location_count": 37, "location_summary": "Dublin, California • Huntington Beach, California • Lake Forest, California + 26 more", "locations": [ { "city": "Dublin", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Lake Forest", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05886777" }, { "nct_id": "NCT06695117", "title": "Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and High-Dose Inactivated Influenza Vaccine in Adult Participants 50 Years of Age and Older", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "COVID-19 Immunization", "Influenza Immunization" ], "interventions": [ { "name": "IIV-HD", "type": "BIOLOGICAL" }, { "name": "rC19 (dose 1)", "type": "BIOLOGICAL" }, { "name": "IIV-HD + rC19 (dose 1)", "type": "BIOLOGICAL" }, { "name": "IIV-HD + rC19 (dose 2)", "type": "BIOLOGICAL" }, { "name": "IIV-HD + rC19 (dose 3)", "type": "BIOLOGICAL" }, { "name": "IIV-HD + rC19 (dose 4)", "type": "BIOLOGICAL" }, { "name": "Placebo (0.9% NaCl)", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 980, "start_date": "2024-11-19", "completion_date": "2026-04-16", "has_results": false, "last_update_posted_date": "2026-05-05", "last_synced_at": "2026-10-02T05:56:29.757Z", "location_count": 12, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Tucson, Arizona + 9 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "The Villages", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06695117" }, { "nct_id": "NCT06178991", "title": "A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Influenza", "COVID-19" ], "interventions": [ { "name": "Influenza and COVID-19 Combination A", "type": "BIOLOGICAL" }, { "name": "Licensed influenza vaccine", "type": "BIOLOGICAL" }, { "name": "COVID-19 Vaccine", "type": "BIOLOGICAL" }, { "name": "Influenza and COVID-19 Combination B", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" }, { "name": "Investigational influenza vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "BioNTech SE", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 8795, "start_date": "2023-12-20", "completion_date": "2024-11-26", "has_results": true, "last_update_posted_date": "2025-12-04", "last_synced_at": "2026-10-02T05:56:29.757Z", "location_count": 106, "location_summary": "Athens, Alabama • Birmingham, Alabama • Mobile, Alabama + 76 more", "locations": [ { "city": "Athens", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06178991" } ] }